We spoke to Dr Benedikt Schrage (Karolinska Institute, Stockholm, Sweden) for the key findings from his prospective study examining the association between the use of implantable cardioverter defibrillators and mortality in patients with heart failure. He also discusses how physicians might incorporate these findings into routine practice.
Speaker’s Disclosures: Benedikt Schrage has received funding from the German Research Foundation and received speaker’s fees from AstraZeneca.
1. What were the key findings from your prospective study that examined the association between implantable cardioverter-defibrillator use and mortality in patients with heart failure? (0:05)
2. How should physicians incorporate these observations into routine practice when considering implantable devices for their patients with heart failure? (1:20)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Filmed at the European Society of Cardiology (ESC) Congress 2019 in Paris, France, September 2019.
Share this Video
Related Videos In Heart Failure
Hugh Calkins, AF Symposium 2021: Atrial Fibrillation and HFrEF and HFpEF
We spoke to Professor Hugh Calkins (Johns Hopkins Hospital, Baltimore, MD, USA) about atrial fibrillation and heart failure with reduced and preserved ejection fraction. Questions: What is the prevalence of atrial fibrillation (AF) in patients with heart failure (HF) and reduced (HFrEF) and preserved (HFpEF) ejection fraction? (0.13) What is the impact of AF on […]
Joachim Ehrlich, ESC 2020 – Cryoballoon Pulmonary Vein Isolation for Atrial Fibrillation with Heart Failure
We caught up with Prof Joachim Ehrlich (Head of Cardiology and Electrophysiology, St Josefs-Hospital, Wiesbaden, Germany) on the recent studies in the use of pulmonary vein isolation in patients with atrial fibrillation and heart failure and the advantages of cryoballoon ablation compared with radiofrequency ablation. He also gave us an overview of their recent cohort […]
Vishal Luther and Eileen Porter, HRC 2019 – Heart Failure and Atrial Fibrillation
We spoke to Dr Vishal Luther (Hammersmith Hospital, London, UK) and patient Eileen Porter at the 2019 Heart Rhythm Congress (HRC) in Birmingham, UK, about heart failure, atrial fibrillation and the patient experience. Speaker’s Disclosures: Vishal Luther has nothing to declare in relation to this video interview. touchCARDIO.com is an independent information resource supporting physicians, […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!